<SEC-DOCUMENT>0001209191-21-023138-index.html : 20210325
<SEC-HEADER>0001209191-21-023138.hdr.sgml : 20210325
<ACCEPTANCE-DATETIME>20210325213853
ACCESSION NUMBER:		0001209191-21-023138
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210325
FILED AS OF DATE:		20210325
DATE AS OF CHANGE:		20210325

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MOORE JOHN R
		CENTRAL INDEX KEY:			0001191702

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40236
		FILM NUMBER:		21774392

	MAIL ADDRESS:	
		STREET 1:		3200 WALNUT ST
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edgewise Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001710072
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				821725586
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		C/O ORBIMED ADVISORS LLC
		STREET 2:		601 LEXINGTON AVE, 54TH FLR.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-739-6451

	MAIL ADDRESS:	
		STREET 1:		C/O ORBIMED ADVISORS LLC
		STREET 2:		601 LEXINGTON AVE, 54TH FLR.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3_975595
<SEQUENCE>2
<FILENAME>poa.txt
<DESCRIPTION>POA DOCUMENT
<TEXT>
Document 2 - file: poa.txt

</DOCUMENT>
</SEC-DOCUMENT>